The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This is a 2-year study proposing to examine the effects of aripiprazole on heart health
factors such as serum lipids, serum leptin, fasting blood sugar, body weight and blood
pressure. This study also examines the safety of switching to aripiprazole with respect to
changes in the clinical state, preexisting or emergent side-effects, how the brain processes
information and changes in social functioning and quality of life.